Romiti, Ricardo https://orcid.org/0000-0003-0165-3831
de Carvalho, André V. E. https://orcid.org/0000-0002-0407-538X
Soares, Cinara P. C. C. https://orcid.org/0009-0000-9721-2963
Duarte, Gleison https://orcid.org/0000-0003-4160-5447
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 4 December 2024
Accepted: 19 March 2025
First Online: 1 April 2025
Declarations
:
: Boehringer Ingelheim was given the opportunity to review the manuscript for medical and scientific accuracy as well as intellectual property considerations. Dr Ricardo Romiti served as a scientific consultant, speaker, or clinical study investigator for AbbVie, Boehringer Ingelheim, Galderma, Janssen-Cilag, Eli-Lilly, Leo-Pharma, Novartis, Pfizer, TEVA, and UCB. Dr André Vicente Esteves de Carvalho received grants, consultancy, and speaking honoraria from AbbVie, Janssen, LeoPharma, Boehringer Ingelheim, Novartis, Eli-Lilly, and UCB. Dr Cinara Prata Cirino Castro Soares is an employee of Boehringer Ingelheim do Brasil. Dr Gleison Duarte received grants, consultancy and speaking honoraria from AbbVie, Bayer, Biolab, Boehringer, Ingelheim, Galderma, Janssen, Eli-Lilly, LeoPharma, UCB, Novartis, and Pfizer.
: In Brazil, a public opinion survey without the possibility of identifying the participant should not be submitted for examination by the Conep System. In Brazil, public opinion polls, without the possibility of identifying the participant, should not be submitted for examination by the ethics committee.